Evoximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Evoximab, covering 2024-04-30 to 2024-04-30. Get the full timeline:
Most recent: Clinical Trial Update: Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer [Phase 2]